Microglia: A cellular vehicle for CNS gene therapy

Journal of Clinical Investigation

Volumn 116, Issue 11, 2006, Pages 2857-2860

  Neumann, Harald ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b Gemeinnutzige Hertie Stiftung   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROSIDE SULFATASE;

BLOOD BRAIN BARRIER; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; GENE THERAPY; INCIDENCE; LYSOSOME STORAGE DISEASE; METACHROMATIC LEUKODYSTROPHY; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVIEW;

ANIMALS; BLOOD-BRAIN BARRIER; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; GENE THERAPY; HEMATOPOIETIC STEM CELLS; LEUKODYSTROPHY, METACHROMATIC; MICROGLIA;

EID: 33750580560     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30230     Document Type: Review

References (17)

1. Niederkorn, J.Y. 2006. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7:354-359.
2. Pardridge, W.M. 2005. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2:3-14.
3. Pardridge, W.M. 2002. Drug and gene delivery to the brain: the vascular route. Neuron. 36:555-558.
4. Ghose, A.K., Viswanadhan, V.N., and Wendoloski, J.J. 1999. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J. Comb. Chem. 1:55-68.
5. Kageyama, T., et al. 2000. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain. Res. 879:115-121.
6. Priller, J., et al. 2001. Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat. Med. 7:1356-1361.
7. Asheuer, M., et al. 2004. Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. Proc. Natl. Acad. Sci. U. S. A. 101:3557-3562.
8. Biffi, A., et al. 2006. Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice. J. Clin. Invest. 116:3070-3082. doi:10.1172/JCI28873.
9. Streit, J.M. 2005. Microglial cells. In Neuroglia. 2nd Edition. Oxford University Press. New York, New York, USA. 60-71.
10. Hickey, W.F., and Kimura, H. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 239:290-292.
11. Simard, A.R., and Rivest, S. 2004. Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J. 18:998-1000.
12. Santambrogio, L., et al. 2001. Developmental plasticity of CNS microglia. Proc. Natl. Acad. Sci. U. S. A. 98:6295-6300.
13. Nimmerjahn, A., Kirchhoff, F., and Helmchen, F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 308:1314-1318.
14. Matzner, U., and Gieselmann, V. 2005. Gene therapy of metachromatic leukodystrophy. Expert Opin. Biol. Ther. 5:55-65.
15. Matzner, U., Harzer, K., Learish, R.D., Barranger, J.A., and Gieselmann, V. 2000. Long-term expression and transfer of arylsulfatase A into brain of arylsulfatase A-deficient mice transplanted with bone marrow expressing the arylsulfatase A cDNA from a retroviral vector. Gene Ther. 7:1250-1257.
16. Biffi, A., et al. 2004. Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. J. Clin. Invest. 113:1118-1129. doi:10.1172/JCI200419205.
17. Hacein-Bey-Abina, S., et al. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 302:415-419.